B
Bernard Levin
Researcher at University of Texas MD Anderson Cancer Center
Publications - 245
Citations - 24891
Bernard Levin is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Colorectal cancer & Cancer. The author has an hindex of 67, co-authored 244 publications receiving 24074 citations. Previous affiliations of Bernard Levin include American Society of Clinical Oncology & University of Chicago.
Papers
More filters
Journal ArticleDOI
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology.
Bernard Levin,David A. Lieberman,Beth McFarland,Kimberly S. Andrews,Durado Brooks,John H. Bond,Chiranjeev Dash,Francis M. Giardiello,Seth N. Glick,David W. Johnson,C. Daniel Johnson,Theodore R. Levin,Perry J. Pickhardt,Douglas K. Rex,Robert A. Smith,Alan G. Thorson,Sidney J. Winawer +16 more
TL;DR: Clinicians should be prepared to offer patients a choice between a screening test that is effective at both early cancer detection and cancer prevention through the detection and removal of polyps and those that can detect cancer early and also can detect adenomatous polyps.
Journal ArticleDOI
The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis
Gideon Steinbach,Patrick M. Lynch,R. K. S. Phillips,Marina Wallace,Ernest T. Hawk,Gary Gordon,Naoki Wakabayashi,Brian D. Saunders,Yu Shen,Takashi Fujimura,Li Kuo Su,Bernard Levin,Louis Godio,Sherri Patterson,Miguel A. Rodriguez-Bigas,Susan L. Jester,Karen L. King,Marta Schumacher,James L. Abbruzzese,Raymond N. DuBois,Walter N. Hittelman,Stuart O. Zimmerman,Jeffrey W. Sherman,Gary J. Kelloff +23 more
TL;DR: In patients with familial adenomatous polyposis, six months of twice-daily treatment with 400 mg of celecoxib, a cyclooxygenase-2 inhibitor, leads to a significant reduction in the number of colorectal polyps.
Journal ArticleDOI
Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline from the American Cancer Society, the US Multi‐Society Task Force on Colorectal Cancer, and the American College of Radiology*†
Bernard Levin,David A. Lieberman,Beth McFarland,Robert A. Smith,Durado Brooks,Kimberly S. Andrews,Chiranjeev Dash,Francis M. Giardiello,Seth N. Glick,Theodore R. Levin,Perry J. Pickhardt,Douglas K. Rex,Alan G. Thorson,Alan G. Thorson,Sidney J. Winawer +14 more
TL;DR: In the United States, colorectal cancer is the third most common cancer diagnosed among men and women and the second leading cause of death from cancer CRC largely can be prevented by the detection and removal of adenomatous polyps, and survival is significantly better when CRC is diagnosed while still localized.
Journal ArticleDOI
Celecoxib for the Prevention of Colorectal Adenomatous Polyps
Nadir Arber,Craig J. Eagle,Julius Spicak,I. Racz,Petr Dite,Jan Hajer,Miroslav Zavoral,Maria Jose Lechuga,Paola Gerletti,Jie Tang,Rebecca B. Rosenstein,Katie Macdonald,Pritha Bhadra,Robert A. Fowler,Janet Wittes,Ann G. Zauber,Scott D. Solomon,Bernard Levin +17 more
TL;DR: The use of 400 mg of celecoxib once daily significantly reduced the occurrence of colorectal adenomas within three years after polypectomy.
Journal ArticleDOI
American Cancer Society Guidelines for the Early Detection of Cancer: Update of Early Detection Guidelines for Prostate, Colorectal, and Endometrial Cancers: ALSO: Update 2001—Testing for Early Lung Cancer Detection
Robert A. Smith,Andrew C. von Eschenbach,Richard C. Wender,Bernard Levin,Tim Byers,David A. Rothenberger,Durado Brooks,William T. Creasman,Carmel J. Cohen,Carolyn D. Runowicz,Debbie Saslow,Vilma Cokkinides,Harmon J. Eyre +12 more
TL;DR: The authors review the “cancer‐related check‐up,” clinical encounters that provide case‐finding and health counseling opportunities, and the ACS is issuing an updated narrative related to testing for early lung cancer detection for clinicians and individuals at high risk of lung cancer in light of emerging data on new imaging technologies.